Agilon Health Raises 2026 Financial Guidance Following Strong Q3 Performance
Agilon Health (AGL) has raised its full-year 2026 financial outlook after exceeding third-quarter guidance across several key metrics. The company now projects 2026 revenue to reach $5.88 billion with an adjusted EBITDA of $150 million. Looking further ahead, management expressed strong confidence in long-term scaling, forecasting ACO membership growth between 40% and 50% for 2027. CEO Timothy O’Rourke attributed the improved guidance to enhanced performance efficiencies within their physician network.
Tickers: $AGL
Topics: earnings beat financial performance guidance increase
Read the full article at Seeking Alpha
Part of the story AbbVie Raises Full-Year Revenue Guidance Following Strong Immunology and Neuroscience Performance (4 articles)